CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding its recent fundraise from a New York-based private investment fund.

According to Sarborg, the subscription was completed at a consideration per share of $125,000, implying a fully diluted valuation of approximately $638.3 million. The proceeds will be used to support the launch and development of SarborgQ, Sarborg's newly formed quantum computing division, alongside continued expansion of the Company's proprietary datasets, acceleration of intellectual property generation, support of asset development activities, and further development of the Sarborg Signature Agent and broader AI platform.

SarborgQ will focus on the application of quantum computing to Sarborg's existing Signature Intelligence platform, with the aim of enhancing its ability to analyse complex biological systems, improve causal inference, and generate higher-resolution signatures across multi-dimensional datasets. The initiative is expected to complement Sarborg's existing computational architecture and expand its analytical capabilities into areas that may be inaccessible through classical computing approaches.

CDT currently owns 1,020 shares in Sarborg, which, based on the price per share paid by the latest investor would imply a value of $127.5 million in respect of CDT's shareholding in Sarborg.

CDT believes the investment represents further third-party validation of Sarborg's business model and follows a period of significant progress by the Company, including the filing of new intellectual property, continued expansion of its proprietary signature databases, and the extension of its platform into additional sectors including agriculture, bacteria, animal health, and other emerging applications.

As a strategic shareholder in Sarborg, CDT believes it is well positioned to benefit from the continued development and commercialisation of Sarborg's Signature Intelligence platform and the expansion of its multi-sector strategy, now further enhanced by the development of SarborgQ.